RNS Number : 7452F
Edita Food Industries S.A.E.
30 October 2018




Edita Food Industries - Summary of Resolutions of the Board of Directors' Meeting convened on 30/10/2018   

Cairo ,October 30 , 2018

Edita Food Industries SAE announces that the Board of Directors Meeting of the Company convened on Tuesday 30 October 2018  and unanimously resolved the following resolutions: -


1.   Approved BOD report for the Company's activities for the financial period ending on September 30,2018.     

2.   Approved the Auditor's limited review report for the standalone and consolidated financial statements for the financial period ending on September 30, 2018.

3.   Approved the Company's standalone and consolidated financial statements for the financial period ending on September 30, 2018.

4.   Approved calling the Extraordinary General Meeting (EGM) to convene, to consider amending article  no.( 21) of Company's AoA, and authorized the Chairman and Managing Director to send the invitation and set the time and place of the meeting. The amendment to include that whoever will be appointed to the membership of the Board of directors shall not be a representative of any competitive company.

5.   Approved the acquisition of Confindel LTD's minority stake in Edita Confectionery Company, which represents  22.27% so that the share of Edita Food Industries S.A.E after the acquisition will be 99.98%, and approval of the Board of Directors to authorize the Chairman and the Managing Director or whom he may authorize to take all the procedures to complete the acquisition and sign all contracts and documents  as well as taking  the necessary procedures to evaluate the shares and determine the purchase price.




Ms. Menna Shams El Din

Investor Relations and Business Development Senior Director
T: +202 3851 6464 | M: +20 100 1542428 |  menna.shamseldin@edita.com.eg


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.